Tag: cancer
-
Microsoft Providing A.I. for Big Data Cancer Research
Seven research teams are receiving grants to study complex problems in cancer immunotherapy with large-scale data sets, and assistance with machine learning and artificial intelligence provided by Microsoft Corp.
-
Grants Made to Commercialize Bone, Cancer Research
A program supporting research with commercial potential awarded grants to scientists studying stem cells for bone grafts, treatments for melanoma, and protein therapies for cancer that change gene expression patterns.
-
T-Cell Therapy Company Gains $100M in Venture Funds
A 2 year-old company developing treatments for cancer and other diseases that activate or suppress the immune system with genetically engineered T-cells is raising $100 million in its first venture funding round.
-
Celgene Acquires Cancer Drug Start-Up in $7B Deal
The biopharmaceutical company Celgene Corp. is acquiring Impact Biomedicines Inc., a developer of drugs to treat a type of blood-related cancer, in a deal valued as much as $7 billion.
-
FDA Clears Targeted Breast Cancer Radiation Treatment
The U.S. Food and Drug Administration approved a device that sends high doses of radiation to cancerous breast tissue while sparing healthy tissue nearby.
-
Phone Sensors Shown to Monitor Chemotherapy Effects
21 December 2017. A group of cancer patients was able to monitor the severity of effects of their chemotherapy with built-in sensors on smartphones and fitness trackers. Results of the clinical study, led by researchers at University of Pittsburgh, appear in the 19 December issue of the Journal of Medical Internet Research. The team from Pittsburgh’s…
-
Biotechs Partner on HPV Cancer Immunotherapies
Biotechnology companies in the U.S. and the Netherlands are collaborating on treatments for cancers caused by a type of human papillomavirus, or HPV.
-
CAR T-Cells Shown Effective in Long-Term Studies
Results from two clinical studies of engineered immune system cells show patients continue to respond their treatments after 6 months or more.
-
Cell Programming Company Raises $49.5M in Early Funds
A start-up enterprise creating add-on treatments that program the effects of cell and gene therapies is raising $49.5 million in its first venture funding round.
-
FDA Approves Precision Solid Tumor Cancer Diagnostics
The Food and Drug Administration approved genomic tests for solid tumor cancers that identify the most promising available therapies matched to the tumor’s genetic mutations.